ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,325Medicare Part D Prescriptions Filled, Including Refills
$493K Total Retail Price of All Prescriptions
702 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 605 596
HYDROCODONE-ACETAMINOPHEN 583 575 S3
OMEPRAZOLE 413 410
LEVOTHYROXINE SODIUM 395 392
LISINOPRIL-HYDROCHLOROTHIAZIDE 290 290
ZOLPIDEM TARTRATE 276 270
FUROSEMIDE 276 271
CITALOPRAM HBR 257 257
LISINOPRIL 247 243
FLUOXETINE HCL 244 238
AMLODIPINE BESYLATE 213 209
METFORMIN HCL 208 208
TRAMADOL HCL 188 180
TRAZODONE HCL 168 160
TAMSULOSIN HCL 165 165
POTASSIUM CHLORIDE 164 158
METOPROLOL SUCCINATE 163 163
WARFARIN SODIUM 138 138
GABAPENTIN 133 133
HYDROCHLOROTHIAZIDE 105 105
TRIAMTERENE-HCTZ 104 104
DIGOXIN 98 95
ATORVASTATIN CALCIUM 92 92
CARBIDOPA-LEVODOPA 90 77
CARVEDILOL 88 88
LOSARTAN POTASSIUM 80 78
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78
GLIMEPIRIDE 77 77
SERTRALINE HCL 74 74
ALENDRONATE SODIUM 74 74
AMITRIPTYLINE HCL 74 74 R
PAROXETINE HCL 74 69
FENTANYL 73 60 S2
FLUTICASONE PROPIONATE 70 69
DONEPEZIL HCL 70 70
IBUPROFEN 65 65
METHYLPHENIDATE HCL 64 58
ALLOPURINOL 58 58
METOLAZONE 57 57
OXYCODONE-ACETAMINOPHEN 55 44 S2
AZITHROMYCIN 53 53
PRAMIPEXOLE DIHYDROCHLORIDE 53 53
ATENOLOL 52 52
SYNTHROID 52 52
BUPROPION HCL 50 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.